WO2017023123A1 - Novel method for preparing chromanone derivative - Google Patents

Novel method for preparing chromanone derivative Download PDF

Info

Publication number
WO2017023123A1
WO2017023123A1 PCT/KR2016/008579 KR2016008579W WO2017023123A1 WO 2017023123 A1 WO2017023123 A1 WO 2017023123A1 KR 2016008579 W KR2016008579 W KR 2016008579W WO 2017023123 A1 WO2017023123 A1 WO 2017023123A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound represented
preparing
acid
reacting
Prior art date
Application number
PCT/KR2016/008579
Other languages
French (fr)
Korean (ko)
Inventor
김은선
고동현
권재홍
김영주
이성아
최광도
허승평
이지윤
Original Assignee
씨제이헬스케어 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 씨제이헬스케어 주식회사 filed Critical 씨제이헬스케어 주식회사
Priority to JP2018505681A priority Critical patent/JP6770057B2/en
Priority to CN201680045379.5A priority patent/CN107848943A/en
Publication of WO2017023123A1 publication Critical patent/WO2017023123A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/10Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with ester groups or with a carbon-halogen bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/307Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708Ethers
    • C07C69/712Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • C07C69/736Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring

Definitions

  • the present invention relates to a novel process for the preparation of 5,7-difluorochroman-4-one derivatives.
  • Chromanone derivatives are substances that are used in medicine and chemistry in a variety of ways, such as the substance itself, or material synthesis process. However, despite the importance of chromanone derivatives, many methods for easily synthesizing them have not been reported.
  • the present invention does not require a separate purification process, has a low manufacturing cost, and can be industrially mass-produced using commercially available reagents and solvents.
  • Provided is a method for preparing a man-4-one derivative.
  • the present invention is a.
  • the preparation method of the present invention does not require a separate purification process, has a low manufacturing cost, and uses 5,7-difluorochroman-4-one derivatives using commercially available reagents and solvents that are not regulated by the environment. Can mass produce effectively.
  • the present invention is a.
  • Reaction of the compound represented by the formula (II) comprising the step of reacting the compound represented by the formula (V) with 2-iodobenzoic acid and potassium peroxymonosulfate (Potassium peroxymonosulfate) It provides a manufacturing method.
  • X may be selected from fluoro, chlorine or iodine with halogen atoms.
  • the reaction is an O-alkylation reaction.
  • the O-alkylation reaction may be used alone or mixed with tetrahydrofuran, dioxane, dichloromethane, 1,2-dimethoxyethane, dimethylformamide (DMF), dimethyl sulfoxide (DMSO) as an organic solvent.
  • Dimethylformamide can be preferably used.
  • potassium hydride sodium hydride, lithium hydride, potassium t-butoxide or the like can be used, and preferably sodium hydride can be used.
  • the compound and base represented by the formula (I) under the organic solvent are stirred at 10 ° C. or lower, preferably 0 ° C. to 10 ° C., and then mixed with the compound represented by the formula to perform an O-alkylation reaction at 60 ° C. to 90 ° C. Can be.
  • X is preferably chlorine.
  • a reaction is a polar solvent, such as Water, methanol, acetonitrile or mixed solvents thereof are used.
  • the compound represented by the formula under a polar solvent may be reacted with 2-Iodobenzoic acid and potassium peroxymonosulfate at 60 ° C to 90 ° C.
  • the reaction is mass-produced by using 2-iodobenzoic acid and potassium peroxymonosulfate, which are generally available without risk, and are not regulatory reagents due to environmental pollution. It is suitable for the process and shows high production yield.
  • the present invention is a.
  • the reaction using copper hydroxide as a base in the Michael addition reaction (Michael addition reaction)
  • the reaction is carried out.
  • copper hydroxide in the Michael addition reaction the present reaction can greatly improve the reaction yield compared to using other base sources.
  • Preparation of the compound represented by the formula (VI) is preferably carried out at 75 °C to 85 °C.
  • the compound represented by the formula (VI) is synthesized by hydrolysis in the presence of an acid or a base.
  • the acid may be selected from sulfuric acid, hydrochloric acid or phosphoric acid, preferably the acid is sulfuric acid.
  • the base may be selected from sodium hydroxide or potassium hydroxide, preferably the base is sodium hydroxide.
  • the step of preparing the compound represented by Formula (II) is preferably performed at 40 ° C. to 60 ° C. under acidic conditions, and under reflux under basic conditions.
  • the present invention is a.
  • a method for preparing a compound represented by the formula (III) comprising a third step of preparing a compound represented by the formula (III) by cyclizing the compound represented by the formula (II).
  • the cyclization reaction may be performed under acidic conditions.
  • the acid may be selected from sulfuric acid, hydrochloric acid or phosphoric acid, preferably sulfuric acid.
  • the reaction in the presence of an acid is preferably reacted at 40 ° C to 60 ° C.
  • the present invention is a.
  • the cyclization reaction may be performed under acidic conditions.
  • Reaction conditions may be applied to the content of the third step of preparing a compound represented by the formula (III) by cyclizing the compound represented by the formula (II) described above.
  • the reaction from formula (VI) to formula (III) may be carried out in an in-situ reaction.
  • the preparation of the compound represented by the formula (I) to the compound represented by the formula (II) is treated with the compound represented by the formula (IV) to the compound represented by the formula (I) after the O-alkylation reaction to 2-benzoic iodide ( 2-Iodobenzoic acid) and potassium peroxymonosulfate (Potassium peroxymonosulfate) may be treated to synthesize the compound represented by Formula II, or may be prepared by hydrolysis after performing a reaction with acrylonitrile.
  • Preparation of the compound represented by the formula (III) from the compound represented by the formula (II) can be prepared by adding a compound represented by the formula (II) in the presence of an acid, and then carrying out a cyclization reaction.
  • the method for preparing a compound represented by Formula (II) according to the present invention may be represented by the following Scheme -1.
  • a compound represented by Formula V is prepared by reacting a compound represented by Formula I with sodium hydride under dimethylformamide, and performing an O-alkylation reaction with a compound of Formula IV.
  • the compound represented by the formula (V) is reacted with 2-iodic benzoic acid and potassium peroxymonosulfate to prepare the compound represented by the formula (II).
  • the preparation method of the compound represented by the formula (III) according to the present invention may be preferably represented by the following reaction scheme (I-1).
  • a compound represented by Formula V is prepared by reacting a compound represented by Formula I with sodium hydride under dimethylformamide, and performing an O-alkylation reaction with a compound of Formula IV.
  • the compound represented by formula (V) is reacted with 2-iodic benzoic acid and potassium peroxymonosulfate to prepare the compound represented by formula (II), and then the sulfuric acid is treated to prepare a compound represented by formula (III) through a cyclization reaction. do.
  • the preparation method of the compound represented by the formula (III) according to the present invention may be preferably represented by the following reaction scheme (I-2).
  • acrylonitrile is reacted under copper hydroxide to prepare a compound of formula VI, and hydrolysis is performed through acid treatment, followed by a cyclization reaction to prepare a compound of formula III.
  • the sulfuric acid treatment reaction may be carried out in the In-situ reaction.
  • the preparation method of the present invention does not require a separate purification process, has a low manufacturing cost, and effectively utilizes 5,7-difluorochroman-4-one using commercially available reagents and solvents that are not regulated by the environment. Can be mass produced industrially.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention relates to a novel method for preparing a 5,7-difluorochroman-4-one derivative. The preparation method according to the present invention allows industrial mass production by using a generally usable reagent and solvent requiring no separate refinement process, having low production costs, and being under no environmental regulation and thus allows a 5,7-difluorochroman-4-one derivative to be efficiently produced.

Description

크로마논 유도체의 신규한 제조방법Novel Method for Preparing Chromanone Derivatives
본 명세서는 2015년 8월 4일에 한국특허청에 제출된 한국 특허 출원 제 10-2015-0110245호의 출원일의 이익을 주장하며, 그 내용 전부는 본 명세서에 포함된다.This specification claims the benefit of the filing date of Korean Patent Application No. 10-2015-0110245 filed with the Korea Intellectual Property Office on August 4, 2015, the entire contents of which are incorporated herein.
본 발명은 5,7-디플루오로크로만-4-온 유도체의 신규한 제조방법에 관한 것이다.The present invention relates to a novel process for the preparation of 5,7-difluorochroman-4-one derivatives.
크로마논 유도체는 의약 및 화학 분야에서 물질 그 자체, 또는 물질 합성 과정 등에 매우 다양하게 이용되는 물질이다. 그런데, 크로마논 유도체의 중요성에도 불구하고, 이를 손쉽게 합성하는 방법은 많이 보고되고 있지 않다.Chromanone derivatives are substances that are used in medicine and chemistry in a variety of ways, such as the substance itself, or material synthesis process. However, despite the importance of chromanone derivatives, many methods for easily synthesizing them have not been reported.
국제공보 WO 2009/156072에는 3,5-디플루오로페놀을 출발물질로 사용하여 5,7-디플루오로크로만-4-온을 제조하는 방법이 기재되어 있다. 상기 특허에는 3,5-디플루오로페놀과 3-클로로-1-프로판올의 O-알킬화 반응을 수행하고, 산화크롬(VI)을 시약으로 사용하여 산화반응을 진행한 후, 마지막으로 옥살릴 클로라이드와 알루미늄 트리클로라이드를 시약으로 고리화 반응을 진행하여 총 60%의 수율로 5.7-디플루오로크로만-4-온을 제조하는 방법이 기재되어 있다.International publication WO 2009/156072 describes a method for preparing 5,7-difluorochroman-4-one using 3,5-difluorophenol as starting material. In this patent, O-alkylation of 3,5-difluorophenol and 3-chloro-1-propanol is carried out, followed by oxidation using chromium (VI) as a reagent, and finally oxalyl chloride. And a method of producing 5.7-difluorochroman-4-one in a total 60% yield by carrying out a cyclization reaction with and aluminum trichloride as a reagent.
그러나 상기 특허에 기재된 제조방법은 각 단계마다 실리카겔 상의 컬럼 크로마토그래피 정제가 필요하여, 공업적인 대량합성의 공정에는 적합하지 않다. 또한, 산화크롬(VI) 시약을 사용한 산화반응을 통해 3-(3,5-디플루오로페녹시)프로판산을 제조하는 과정에서, 환경규제가 심한 중금속 산화제 산화크롬(VI)을 사용하기 때문에, 해당 공정은 대량생산 시 매우 부적절하다. 아울러, 상기 반응에서 사용하는 용매는 출발물질 대비 150배 정도로 반응 후 폐액 처리로 인한 비용이 추가로 드는 문제점이 있다. 즉, 상기 WO 2009/156072에 기재된 방법에 따르면, 제조원가가 높아지고 환경 규제가 심한 중금속을 사용하는 문제점이 있어, 대량 생산에 적합한 공정이 아니다.However, the production method described in the above patent requires column chromatography purification on silica gel at each step, which is not suitable for industrial mass synthesis processes. In addition, in the process of preparing 3- (3,5-difluorophenoxy) propanoic acid through an oxidation reaction using a chromium oxide (VI) reagent, heavy metal oxidant chromium oxide (VI) is used. This process is very inadequate for mass production. In addition, the solvent used in the reaction has a problem that additional cost due to waste liquid treatment after the reaction about 150 times compared to the starting material. That is, according to the method described in WO 2009/156072, there is a problem of using heavy metals with high manufacturing costs and severe environmental regulations, which is not a suitable process for mass production.
또한, 3,5-디플루오로페놀과 아크릴로니트릴을 출발물질로 하여 5,7-디플루오로크로만-4-온을 제조하는 방법이 국제공보 WO 2005/016896에 기재되어있다. 상기 특허에는 3,5-디플루오로페놀과 아크릴로니트릴로 마이클(Michael) 반응을 수행하여, 35%의 수율로 3-(3,5-디플루오로페녹시)프로피오니트릴을 제조하였다. 다음으로 진한 염산으로 가수분해를 진행하여 3-(3,5-디플루오로페녹시)프로피온산을 76%의 수율로 제조한 후, 마지막으로 티오닐 클로라이드를 이용하여 고리화하여 5,7-디플루오로크로만-4-온을 73%의 수율로 제조하였다. 그러나 상기 특허에 기재된 제조방법 역시 실리카겔 상의 컬럼 크로마토그래피로 정제하여 일반적으로 공업적인 대량합성의 공정에는 적합하지 않다. 또한 마지막 공정에서 -65까지 냉각하는 공정이 필요하기 때문에 실생산에 적용할 수 없는 문제점이 있다. In addition, a process for producing 5,7-difluorochroman-4-one using 3,5-difluorophenol and acrylonitrile as starting materials is described in International Publication WO 2005/016896. The patent carried out a Michael reaction with 3,5-difluorophenol and acrylonitrile to prepare 3- (3,5-difluorophenoxy) propionitrile in a yield of 35%. Next, hydrolysis was carried out with concentrated hydrochloric acid to prepare 3- (3,5-difluorophenoxy) propionic acid in a yield of 76%, and finally cyclized with thionyl chloride to give 5,7-di Fluorochroman-4-one was prepared in a yield of 73%. However, the process described in this patent is also purified by column chromatography on silica gel and is generally not suitable for industrial mass synthesis processes. In addition, there is a problem that can not be applied to the actual production because it requires a process to cool to -65 in the last process.
이에 따라, 낮은 제조 원가를 가지며 통상적으로 사용 가능한 시약과 용매를 사용하여, 산업적으로 대량생산이 가능하고 환경 규제도 받지 않는 의약 및 화학분야에서 매우 중요한 약물 특이 분자단인 5,7-디플루오로크로만-4-온을 대량생산할 수 있는 신규한 제조방법이 필요한 실정이다.As a result, 5,7-difluoro, a drug-specific molecular group that is very important in the pharmaceutical and chemical industries that can be industrially mass-produced and environmentally regulated, using low production costs and commercially available reagents and solvents There is a need for a new manufacturing method for mass production of chromoman-4-one.
[선행기술문헌][Preceding technical literature]
[특허문헌][Patent Documents]
국제공개특허 제 2009/156072호International Publication No. 2009/156072
국제공개특허 제 2005/016896호International Publication No. 2005/016896
본 발명은 별도의 정제 공정이 필요하지 않고 낮은 제조 원가를 가지며, 통상적으로 사용 가능한 시약과 용매를 사용하여 산업적으로 대량생산이 가능하고 제법상 환경 규제도 받지 않는 우수한 5,7-디플루오로크로만-4-온 유도체의 제조방법을 제공한다.The present invention does not require a separate purification process, has a low manufacturing cost, and can be industrially mass-produced using commercially available reagents and solvents. Provided is a method for preparing a man-4-one derivative.
본 발명은 The present invention
하기 화학식 Ⅰ로 표시되는 화합물로부터 화학식 Ⅱ로 표시되는 화합물을 제조하는 단계; 및 Preparing a compound represented by formula (II) from a compound represented by formula (I); And
상기 화학식 Ⅱ로 표시되는 화합물을 고리화 반응시켜 화학식 Ⅲ으로 표시되는 화합물을 제조하는 단계를 포함하는, 화학식 Ⅲ으로 표시되는 화합물의 제조 방법을 제공한다:It provides a process for the preparation of a compound represented by the formula (III) comprising the step of preparing a compound represented by the formula (III) by cyclizing the compound represented by the formula (II):
[화학식 I][Formula I]
Figure PCTKR2016008579-appb-I000001
Figure PCTKR2016008579-appb-I000001
[화학식 II][Formula II]
Figure PCTKR2016008579-appb-I000002
Figure PCTKR2016008579-appb-I000002
[화학식 Ⅲ][Formula III]
Figure PCTKR2016008579-appb-I000003
Figure PCTKR2016008579-appb-I000003
본 발명의 제조방법은 별도의 정제 공정이 필요하지 않고 낮은 제조 원가를 가지며, 환경 규제도 받지 않는 통상적으로 사용 가능한 시약과 용매를 사용하여 5,7-디플루오로크로만-4-온 유도체를 효과적으로 대량 생산할 수 있다. The preparation method of the present invention does not require a separate purification process, has a low manufacturing cost, and uses 5,7-difluorochroman-4-one derivatives using commercially available reagents and solvents that are not regulated by the environment. Can mass produce effectively.
본 발명은 The present invention
상기 화학식 Ⅰ로 표시되는 화합물과 하기 화학식 Ⅳ로 표시되는 화합물을 반응시켜 하기 화학식 Ⅴ로 표시되는 화합물을 제조하는 단계; 및Preparing a compound represented by Chemical Formula V by reacting the compound represented by Chemical Formula I with the compound represented by Chemical Formula IV; And
상기 화학식 Ⅴ로 표시되는 화합물에 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)를 반응시켜 상기 화학식 Ⅱ의 화합물을 제조하는 단계를 포함하는 화학식 Ⅱ로 표시되는 화합물의 제조 방법을 제공한다.Reaction of the compound represented by the formula (II) comprising the step of reacting the compound represented by the formula (V) with 2-iodobenzoic acid and potassium peroxymonosulfate (Potassium peroxymonosulfate) It provides a manufacturing method.
[화학식 Ⅳ][Formula IV]
Figure PCTKR2016008579-appb-I000004
Figure PCTKR2016008579-appb-I000004
[화학식 Ⅴ] [Formula Ⅴ]
Figure PCTKR2016008579-appb-I000005
Figure PCTKR2016008579-appb-I000005
상기 화학식 Ⅳ에서,In Chemical Formula IV,
X는 할로겐 원자로 플루오로, 염소 또는 요오드로부터 선택될 수 있다. X may be selected from fluoro, chlorine or iodine with halogen atoms.
상기 화학식 Ⅰ로 표시되는 화합물과 상기 화학식 Ⅳ로 표시되는 화합물을 반응시켜 상기 화학식 Ⅴ로 표시되는 화합물을 제조하는 제1 단계에서, 상기 반응은 O-알킬화 반응이다. In a first step of preparing a compound represented by Formula V by reacting the compound represented by Formula I with the compound represented by Formula IV, the reaction is an O-alkylation reaction.
상기 O-알킬화 반응은 유기 용매로 테트라하이드로퓨란, 디옥산, 디클로로메탄, 1,2-디메톡시에탄, 디메틸포름아미드(DMF), 디메틸설폭사이드(DMSO) 등을 단독으로 또는 혼합하여 사용할 수 있고, 바람직하게 디메틸포름아미드를 사용할 수 있다. The O-alkylation reaction may be used alone or mixed with tetrahydrofuran, dioxane, dichloromethane, 1,2-dimethoxyethane, dimethylformamide (DMF), dimethyl sulfoxide (DMSO) as an organic solvent. Dimethylformamide can be preferably used.
또한, O-알킬화 반응에서 사용되는 염기는 수소화칼륨, 수소화나트륨, 수소화리튬, 포타슘 t-부톡사이드(potassium t-butoxide) 등을 사용할 수 있고, 바람직하게, 수소화나트륨을 사용할 수 있다. In addition, as the base used in the O-alkylation reaction, potassium hydride, sodium hydride, lithium hydride, potassium t-butoxide or the like can be used, and preferably sodium hydride can be used.
상기 유기 용매 하에 화학식 Ⅰ로 표시되는 화합물 및 염기는 10℃ 이하, 바람직하게는 0℃ 내지 10℃ 에서 교반된 후, 화학식 로 표시되는 화합물과 혼합되어 60℃ 내지 90℃ 에서 O-알킬화 반응이 수행될 수 있다. The compound and base represented by the formula (I) under the organic solvent are stirred at 10 ° C. or lower, preferably 0 ° C. to 10 ° C., and then mixed with the compound represented by the formula to perform an O-alkylation reaction at 60 ° C. to 90 ° C. Can be.
상기 화학식 Ⅳ로 표시되는 화합물에 있어서, 상기 X는 염소인 것이 바람직하다. In the compound represented by the above formula (IV), X is preferably chlorine.
상기 화학식 Ⅴ로 표시되는 화합물에 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)를 반응시켜 화학식 Ⅱ의 화합물을 제조하는 제2 단계에서, 반응은 극성 용매, 예컨대, 물, 메탄올, 아세토니트릴 또는 이의 혼합 용매를 사용한다. In a second step of preparing a compound represented by Chemical Formula II by reacting 2-iodobenzoic acid and potassium peroxymonosulfate with potassium peroxymonosulfate, the reaction is a polar solvent, such as Water, methanol, acetonitrile or mixed solvents thereof are used.
극성 용매 하에 화학식 로 표시되는 화합물은 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)와 60℃ 내지 90℃ 에서 반응이 수행될 수 있다. The compound represented by the formula under a polar solvent may be reacted with 2-Iodobenzoic acid and potassium peroxymonosulfate at 60 ° C to 90 ° C.
상기 반응은 기존에 알려진 반응들과 달리 환경 오염에 따른 규제 시약이 아닌 일반적으로 위험부담 없이 사용 가능한 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)을 사용함으로써 대량생산 공정에 적합하며 높은 제조 수율을 나타낸다.Unlike the known reactions, the reaction is mass-produced by using 2-iodobenzoic acid and potassium peroxymonosulfate, which are generally available without risk, and are not regulatory reagents due to environmental pollution. It is suitable for the process and shows high production yield.
본 발명은 The present invention
화학식 I로 표시되는 화합물을 염기 하에 아크릴로니트릴과 반응시켜 하기 화학식 Ⅵ으로 표시되는 화합물을 제조하는 제1 단계; 및 Reacting a compound represented by the formula (I) with acrylonitrile under a base to prepare a compound represented by the following formula (VI); And
화학식 Ⅵ으로 표시되는 화합물을 가수분해하여 화학식 Ⅱ로 표시되는 화합물을 제조하는 제2 단계를 포함하고, A second step of preparing a compound represented by formula II by hydrolyzing the compound represented by formula VI;
상기 제1 단계의 염기는 수산화 구리인 것인 화학식 Ⅱ로 표시되는 화합물의 제조 방법을 제공한다.Provided is a method for preparing a compound represented by Formula II, wherein the base of the first step is copper hydroxide.
[화학식 Ⅵ][Formula VI]
Figure PCTKR2016008579-appb-I000006
Figure PCTKR2016008579-appb-I000006
상기 화학식 I로 표시되는 화합물을 수산화구리를 염기로서 이용하여 아크릴로니트릴과 반응시켜 화학식 화합물을 제조하는 제1 단계에 있어서, 상기 반응은 마이클 부가 반응(Michael addition reaction)으로 염기로써 수산화 구리를 사용하여 반응이 수행된다. 본 반응은 마이클 부가 반응에서 수산화 구리를 사용함으로써 타 염기원을 사용하는 것과 대비하여 반응 수율을 크게 향상시킬 수 있다. In the first step of preparing a chemical compound by reacting the compound represented by the formula (I) with acrylonitrile using copper hydroxide as a base, the reaction using copper hydroxide as a base in the Michael addition reaction (Michael addition reaction) The reaction is carried out. By using copper hydroxide in the Michael addition reaction, the present reaction can greatly improve the reaction yield compared to using other base sources.
화학식 Ⅵ으로 표시되는 화합물을 제조하는 단계는 75℃ 내지 85℃ 에서 수행되는 것이 바람직하다. Preparation of the compound represented by the formula (VI) is preferably carried out at 75 ℃ to 85 ℃.
상기 화학식 Ⅵ으로 표시되는 화합물을 가수분해하여 화학식 Ⅱ로 표시되는 화합물을 제조하는 제2 단계에 있어서, 산 또는 염기의 존재 하에 가수분해를 통해 화학식 Ⅵ으로 표시되는 화합물을 합성한다. 산은 황산, 염산 또는 인산으로부터 선택될 수 있으며, 바람직하게 산은 황산이다. 염기는 수산화 나트륨 또는 수산화 칼륨으로부터 선택될 수 있으며, 바람직하게 염기는 수산화 나트륨이다. In the second step of preparing a compound represented by the formula (II) by hydrolysis of the compound represented by the formula (VI), the compound represented by the formula (VI) is synthesized by hydrolysis in the presence of an acid or a base. The acid may be selected from sulfuric acid, hydrochloric acid or phosphoric acid, preferably the acid is sulfuric acid. The base may be selected from sodium hydroxide or potassium hydroxide, preferably the base is sodium hydroxide.
화학식 Ⅱ로 표시되는 화합물을 제조하는 단계는 산 조건에서는 40℃ 내지 60℃ 에서 수행되는 것이 바람직하고 염기 조건에서는 환류 조건에서 수행되는 것이 바람직하다. The step of preparing the compound represented by Formula (II) is preferably performed at 40 ° C. to 60 ° C. under acidic conditions, and under reflux under basic conditions.
본 발명은 The present invention
화학식 Ⅰ로 표시되는 화합물과 화학식 Ⅳ로 표시되는 화합물을 반응시켜 화학식 Ⅴ로 표시되는 화합물을 제조하는 제1 단계; A first step of preparing a compound represented by Formula V by reacting the compound represented by Formula I with the compound represented by Formula IV;
화학식 Ⅴ로 표시되는 화합물에 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)를 반응시켜 화학식 Ⅱ의 화합물을 제조하는 제2 단계; 및A second step of preparing a compound of Formula II by reacting 2-iodobenzoic acid with potassium peroxymonosulfate with 2-Iodobenzoic acid; And
화학식 Ⅱ로 표시되는 화합물을 고리화 반응시켜 화학식 Ⅲ으로 표시되는 화합물을 제조하는 제3 단계를 포함하는 화학식 Ⅲ으로 표시되는 화합물의 제조 방법을 제공한다. Provided is a method for preparing a compound represented by the formula (III) comprising a third step of preparing a compound represented by the formula (III) by cyclizing the compound represented by the formula (II).
상기 제조 방법에서, 앞선 두 단계는 앞에서 살핀 바와 같다. In the above production process, the two preceding steps are as described above.
화학식 Ⅱ로 표시되는 화합물을 고리화 반응시켜 화학식 Ⅲ으로 표시되는 화합물을 제조하는 제3 단계는 산 조건 하에 고리화 반응이 수행될 수 있다. In the third step of preparing a compound represented by Formula III by cyclizing the compound represented by Formula II, the cyclization reaction may be performed under acidic conditions.
상기 산은 황산, 염산 또는 인산으로부터 선택될 수 있으며, 바람직하게는 황산이다. 산 존재 하의 반응은 40℃ 내지 60℃ 에서 반응되는 것이 바람직하다.The acid may be selected from sulfuric acid, hydrochloric acid or phosphoric acid, preferably sulfuric acid. The reaction in the presence of an acid is preferably reacted at 40 ° C to 60 ° C.
본 발명은 The present invention
화학식 I로 표시되는 화합물을 염기 하에 아크릴로니트릴과 반응시켜 화학식 화합물을 제조하는 제1 단계; A first step of preparing a compound of formula by reacting a compound of formula (I) with acrylonitrile under a base;
화학식 Ⅵ으로 표시되는 화합물을 가수분해하여 화학식 Ⅱ로 표시되는 화합물을 제조하는 제2 단계; 및A second step of preparing a compound represented by Chemical Formula II by hydrolyzing the compound represented by Chemical Formula VI; And
화학식 Ⅱ로 표시되는 화합물을 고리화 반응시켜 화학식 Ⅲ으로 표시되는 화합물을 제조하는 제3 단계를 포함하고, And a third step of preparing a compound represented by Chemical Formula III by cyclizing the compound represented by Chemical Formula II,
상기 제1 단계의 염기는 수산화 구리인 것인 화학식 Ⅲ으로 표시되는 화합물의 제조방법을 제공한다. Provided is a method for preparing a compound represented by Formula III, wherein the base of the first step is copper hydroxide.
상기 제조 방법에서, 앞선 두 단계는 앞에서 살핀 바와 같다. In the above production process, the two preceding steps are as described above.
화학식 Ⅱ로 표시되는 화합물을 고리화 반응시켜 화학식 Ⅲ으로 표시되는 화합물을 제조하는 제3 단계는 산 조건 하에 고리화 반응이 수행될 수 있다. In the third step of preparing a compound represented by Formula III by cyclizing the compound represented by Formula II, the cyclization reaction may be performed under acidic conditions.
반응 조건은 상기 기재된 화학식 Ⅱ로 표시되는 화합물을 고리화 반응시켜 화학식 Ⅲ으로 표시되는 화합물을 제조하는 제3 단계의 내용이 적용될 수 있다. 화학식 Ⅵ에서 화학식 Ⅲ으로의 반응은 In-situ 반응으로 수행될 수 있다. Reaction conditions may be applied to the content of the third step of preparing a compound represented by the formula (III) by cyclizing the compound represented by the formula (II) described above. The reaction from formula (VI) to formula (III) may be carried out in an in-situ reaction.
예를 들면, 본 발명에 따른 화학식 Ⅲ으로 표시되는 화합물의 제조 방법은 하기 반응식 I로 표시될 수 있다. For example, the method for preparing a compound represented by Formula III according to the present invention may be represented by the following Scheme I.
[반응식 I]Scheme I
Figure PCTKR2016008579-appb-I000007
Figure PCTKR2016008579-appb-I000007
상기 식에서와 같이, 화학식 I로 표시되는 화합물부터 화학식 Ⅱ로 표시되는 화합물의 제조는 화학식 I로로 표시되는 화합물에 화학식 Ⅳ로 표시되는 화합물을 처리하여 O-알킬화 반응을 수행한 후 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)를 처리하여 화학식 Ⅱ로 표시되는 화합물을 합성하거나, 아크릴로니트릴과 반응을 수행한 후 가수분해하여 제조할 수 있다. As in the above formula, the preparation of the compound represented by the formula (I) to the compound represented by the formula (II) is treated with the compound represented by the formula (IV) to the compound represented by the formula (I) after the O-alkylation reaction to 2-benzoic iodide ( 2-Iodobenzoic acid) and potassium peroxymonosulfate (Potassium peroxymonosulfate) may be treated to synthesize the compound represented by Formula II, or may be prepared by hydrolysis after performing a reaction with acrylonitrile.
화학식 Ⅱ로 표시되는 화합물로부터 화학식 Ⅲ으로 표시되는 화합물의 제조는 산 존재 하에 화학식 Ⅱ로 표시되는 화합물을 첨가한 후, 고리화 반응을 수행하여 제조할 수 있다. Preparation of the compound represented by the formula (III) from the compound represented by the formula (II) can be prepared by adding a compound represented by the formula (II) in the presence of an acid, and then carrying out a cyclization reaction.
본 발명에 따른 화학식 Ⅱ로 표시되는 화합물의 제조 방법은 하기 반응식 -1로 표시될 수 있다. The method for preparing a compound represented by Formula (II) according to the present invention may be represented by the following Scheme -1.
[반응식 Ⅱ-1]Scheme II-1
Figure PCTKR2016008579-appb-I000008
Figure PCTKR2016008579-appb-I000008
상기 반응식 Ⅱ-1에서와 같이, 디메틸포름아미드 하에 화학식 I 로 표시되는 화합물과 수소화나트륨을 반응시키고, 화학식 Ⅳ의 화합물과 O-알킬화 반응을 수행하여 화학식 Ⅴ로 표시되는 화합물을 제조한다. 제조된 화학식 Ⅴ로 표시되는 화합물을 2-요오드화벤조산 및 포타슘 퍼옥시모노설페이트와 반응시켜 화학식 Ⅱ로 표시되는 화합물을 제조한다. As in Scheme II-1, a compound represented by Formula V is prepared by reacting a compound represented by Formula I with sodium hydride under dimethylformamide, and performing an O-alkylation reaction with a compound of Formula IV. The compound represented by the formula (V) is reacted with 2-iodic benzoic acid and potassium peroxymonosulfate to prepare the compound represented by the formula (II).
본 발명에 따른 화학식 Ⅱ로 표시되는 화합물의 제조 방법은 하기 반응식 Ⅱ-2로 표시될 수 있다. The method for preparing a compound represented by Formula II according to the present invention may be represented by the following Scheme II-2.
[반응식 Ⅱ-2][Scheme II-2]
Figure PCTKR2016008579-appb-I000009
Figure PCTKR2016008579-appb-I000009
상기 반응식 Ⅱ-2에서와 같이, 수산화 구리 하에 아크릴노니트릴을 반응시켜 화학식 Ⅵ의 화합물을 제조하고, 산처리를 통해 가수분해를 수행하여 화학식 Ⅱ로 표시되는 화합물을 제조한다. As in Scheme II-2, acrylonitrile is reacted under copper hydroxide to prepare a compound of formula VI, and hydrolysis is performed through acid treatment to prepare a compound represented by formula II.
본 발명에 따른 화학식 Ⅲ으로 표시되는 화합물의 제조 방법은 바람직하게하기 반응식 I-1로 표시될 수 있다.The preparation method of the compound represented by the formula (III) according to the present invention may be preferably represented by the following reaction scheme (I-1).
[반응식 I-1]Scheme I-1
Figure PCTKR2016008579-appb-I000010
Figure PCTKR2016008579-appb-I000010
상기 반응식 I-1에서와 같이, 디메틸포름아미드 하에 화학식 I 로 표시되는 화합물과 수소화나트륨을 반응시키고, 화학식 Ⅳ의 화합물과 O-알킬화 반응을 수행하여 화학식 Ⅴ로 표시되는 화합물을 제조한다. 제조된 화학식 Ⅴ로 표시되는 화합물을 2-요오드화벤조산 및 포타슘 퍼옥시모노설페이트와 반응시켜 화학식 Ⅱ로 표시되는 화합물을 제조한 후, 황산을 처리하여 고리화 반응을 통해 화학식 Ⅲ으로 표시되는 화합물을 제조한다. As in Scheme I-1, a compound represented by Formula V is prepared by reacting a compound represented by Formula I with sodium hydride under dimethylformamide, and performing an O-alkylation reaction with a compound of Formula IV. The compound represented by formula (V) is reacted with 2-iodic benzoic acid and potassium peroxymonosulfate to prepare the compound represented by formula (II), and then the sulfuric acid is treated to prepare a compound represented by formula (III) through a cyclization reaction. do.
본 발명에 따른 화학식 Ⅲ으로 표시되는 화합물의 제조 방법은 바람직하게 하기 반응식 I-2로 표시될 수 있다.The preparation method of the compound represented by the formula (III) according to the present invention may be preferably represented by the following reaction scheme (I-2).
[반응식 I-2]Scheme I-2
Figure PCTKR2016008579-appb-I000011
Figure PCTKR2016008579-appb-I000011
상기 반응식 I-2에서와 같이, 수산화 구리 하에 아크릴노니트릴을 반응시켜 화학식 Ⅵ의 화합물을 제조하고, 산처리를 통해 가수분해를 수행한 후 고리화 반응을 진행하여 화학식 Ⅲ의 화합물을 제조한다. 여기서, 황산 처리 반응은 In-situ 반응으로 수행될 수 있다.As in Scheme I-2, acrylonitrile is reacted under copper hydroxide to prepare a compound of formula VI, and hydrolysis is performed through acid treatment, followed by a cyclization reaction to prepare a compound of formula III. Here, the sulfuric acid treatment reaction may be carried out in the In-situ reaction.
본 발명의 제조방법은 별도의 정제 공정이 필요하지 않고 낮은 제조 원가를 가지며, 환경 규제도 받지 않는 통상적으로 사용 가능한 시약과 용매를 사용하여 5,7-디플루오로크로만-4-온을 효과적으로 산업적으로 대량생산할 수 있다.The preparation method of the present invention does not require a separate purification process, has a low manufacturing cost, and effectively utilizes 5,7-difluorochroman-4-one using commercially available reagents and solvents that are not regulated by the environment. Can be mass produced industrially.
이하, 하기 실시예 및 실험예를 통하여 본 발명을 보다 상세히 설명하고자 한다. 그러나, 하기 실시예 및 실험예는 본 발명을 예시하기 위한 것으로 이들 실시예 및 실험예에 의하여 본 발명의 범위가 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to the following examples and experimental examples. However, the following Examples and Experimental Examples are provided to illustrate the present invention, and the scope of the present invention is not limited by these Examples and Experimental Examples.
이하에서 언급된 시약 및 용매는 특별한 언급이 없는 한 Sigma Aldrich로부터 구입한 것이며, 1H-NMR는 Bruker NMR 400MHz로 측정하였다. The reagents and solvents mentioned below were purchased from Sigma Aldrich unless otherwise noted, and 1 H-NMR was measured by Bruker NMR 400 MHz.
실시예 1: 3-(3,5-디플루오로페녹시)프로판-1-올의 제조Example 1: Preparation of 3- (3,5-difluorophenoxy) propan-1-ol
반응기에 수소화나트륨 36 kg과 디메틸포름아미드 439 kg을 투입하고, 0 ℃로 냉각하였다. 별도로 디메틸포름아미드 165 kg에 3,5-디플루오로페놀 116 kg을 용해시키고 5 ℃이하에서 반응기에 적가한 후 교반하였다. 또한, 디메틸포름아미드 165 kg에 3-클로로-1-프로판올 108 kg을 용해시키고 반응기에 적가한 후 80 ℃로 승온하여 반응하였다. 반응이 종결된 후 20 ℃로 냉각하고, 디이소프로필에테르 839 kg 및 정제수 530 kg을 투입하였다. 그 후 진한염산 48 kg을 적가하고 교반하였다. 층 분리 후, 유기층에 5% 수산화나트륨 수용액(수산화나트륨 29 kg + 정제수 579 kg)을 투입하여 교반하고, 유기층을 분리하여 40 ℃에서 진공 농축하여 3-(3,5-디플루오로페녹시)프로판-1-올(167 kg, 100%, in-situ)을 수득하였다.36 kg of sodium hydride and 439 kg of dimethylformamide were added to the reactor, and the mixture was cooled to 0 ° C. Separately, 116 kg of 3,5-difluorophenol was dissolved in 165 kg of dimethylformamide, and added dropwise to the reactor at 5 ° C. or lower, followed by stirring. In addition, 108 kg of 3-chloro-1-propanol was dissolved in 165 kg of dimethylformamide, added dropwise to the reactor, and the reaction was heated to 80 ° C. After the reaction was completed, the reaction mixture was cooled to 20 ° C, and 839 kg of diisopropyl ether and 530 kg of purified water were added thereto. Then 48 kg of concentrated hydrochloric acid was added dropwise and stirred. After separation of the layers, 5% aqueous sodium hydroxide solution (29 kg of sodium hydroxide + 579 kg of purified water) was added to the organic layer, followed by stirring. The organic layer was separated and concentrated in vacuo at 40 ° C. to give 3- (3,5-difluorophenoxy). Propan-1-ol (167 kg, 100%, in-situ) was obtained.
1H-NMR (400MHz, DMSO-d6): δ= 1.84 (quint, 2H), 3.54 (dd, 2H), 4.06 (t, 2H), 4.57 (t, 1H) 1 H-NMR (400 MHz, DMSO-d 6 ): δ = 1.84 (quint, 2H), 3.54 (dd, 2H), 4.06 (t, 2H), 4.57 (t, 1H)
실시예Example 2: 32: 3 -(3,5--(3,5- 디플루오로페녹시Difluorophenoxy )) 프로파노익Propanoic 산의 제조 Manufacture of acid
반응기에 3-(3,5-디플로로펜옥시)프로판-1-올 167 kg, 아세토니트릴 882 kg 및 정제수 552 kg을 투입한 후 교반하고, 2-요오드화벤조산 11 kg 및 포타슘 퍼옥시모노설페이트 227 kg을 투입하여 80℃ 에서 교반하였다. 반응이 종결된 후에 5℃ 이하로 냉각하고 에틸아세테이트 1201 kg 및 정제수 1339 kg을 투입하여 교반하였다. 석출된 고체를 여과하고 에틸아세테이트 300 kg, 정제수 335kg를 이용하여 세척하였다. 여과액을 40℃ 에서 진공 농축하고, 헵탄 569 kg을 투입하고 20 ℃로 냉각하여 교반하였다. 여과 후 40℃ 에서 진공건조하여 3-(3,5-디플로로펜옥시)프로파노익 산(142kg, 79%)을 수득하였다. 167 kg of 3- (3,5-difluorophenoxy) propan-1-ol, 882 kg of acetonitrile and 552 kg of purified water were added to the reactor, followed by stirring. 11 kg of 2-iodic benzoic acid and potassium peroxymonosulfate were added. 227 kg were added and stirred at 80 ° C. After the reaction was completed, the mixture was cooled to 5 ° C. or lower, and 1201 kg of ethyl acetate and 1339 kg of purified water were added and stirred. The precipitated solid was filtered and washed with 300 kg of ethyl acetate and 335 kg of purified water. The filtrate was concentrated in vacuo at 40 ° C, 569 kg of heptanes were added, cooled to 20 ° C and stirred. After filtration, vacuum drying at 40 ° C. yielded 3- (3,5-difluorophenoxy) propanoic acid (142 kg, 79%).
1H-NMR (400MHz, DMSO-d6): δ= 2.69 (t, 2H), 4.19 (t, 2H), 6.68-6.81 (m, 3H), 12.4 (s, 1H) 1 H-NMR (400 MHz, DMSO-d 6 ): delta = 2.69 (t, 2H), 4.19 (t, 2H), 6.68-6.81 (m, 3H), 12.4 (s, 1H)
실시예 3: 5,7-디플루오로크로만-4-온의 제조Example 3: Preparation of 5,7-difluorochroman-4-one
반응기 A에 진한 황산 345 kg을 투입하고, 10℃ 로 냉각하여 3-(3,5-디플로로펜옥시)프로파노익 산 142 kg을 적가하였다. 50℃ 에서 교반 후, 반응이 종결되면 20℃ 로 냉각시켰다. 반응기 B에 정제수 1421 kg을 투입하고, 0℃ 로 냉각하였다. 상기 반응기 A의 반응물을 10℃ 이하로 유지하면서 상기 반응기 B에 천천히 적가하고, 디클로로메탄 1890 kg을 가하고 교반하였다. 유기층을 분리 후, 정제수 1421 kg을 가하고 5% 탄산나트륨 수용액(탄산나트륨 14 kg + 정제수 284 kg)을 이용하여 pH 7.5를 맞췄다. 유기층을 분리하여 40℃ 에서 진공농축하고, 헵탄 483 kg을 투입하여 교반하였다. 여과 후 40℃ 에서 진공건조하여, 5,7-디플루오로크로만-4-온(109 kg, 84%)을 수득하였다. 345 kg of concentrated sulfuric acid was added to Reactor A, cooled to 10 ° C, and 142 kg of 3- (3,5-difluorophenoxy) propanoic acid was added dropwise. After stirring at 50 ° C., the reaction was cooled to 20 ° C. after completion of the reaction. 1421 kg of purified water was added to Reactor B, and it cooled to 0 degreeC. The reactant of Reactor A was slowly added dropwise to Reactor B while maintaining below 10 ° C., 1890 kg of dichloromethane was added and stirred. After separating the organic layer, 1421 kg of purified water was added and 5% aqueous sodium carbonate solution (sodium carbonate 14 kg + 284 kg purified water) to pH 7.5. The organic layer was separated, concentrated in vacuo at 40 ° C, and 483 kg of heptane was added and stirred. Vacuum drying at 40 ° C. after filtration gave 5,7-difluorochroman-4-one (109 kg, 84%).
1H-NMR (400MHz, DMSO-d6): δ= 2.77 (t, 2H), 4.57 (t, 2H), 6.81-6.95 (m, 2H) 1 H-NMR (400 MHz, DMSO-d 6 ): delta = 2.77 (t, 2H), 4.57 (t, 2H), 6.81-6.95 (m, 2H)
실시예 4: 3-(3,5-디플루오로페녹시)프로판니트릴의 제조Example 4: Preparation of 3- (3,5-difluorophenoxy) propanenitrile
반응기에 3,5-디플루오로페놀 13 kg과 아크릴로니트릴 21 kg을 투입 후 교반하였다. 수산화구리 5 kg을 투입하고 80 ℃에서 48시간 동안 환류하였다. 반응 종결 후 상온으로 냉각하고, 50℃ 에서 농축하였다. 디클로로메탄 100L와 정제수 50L을 투입하고 교반하였다. 유기층에 정제수 50L를 투입 후, 교반하여 유기층을 분리하였다. 그 후, 무수 황산마그네슘을 이용하여 건조하고 용매를 감압 제거함으로써 3-(3,5-디플루오로페녹시)프로판니트릴(11 kg, 60%)을 수득하였다. 13 kg of 3,5-difluorophenol and 21 kg of acrylonitrile were added to the reactor, followed by stirring. 5 kg of copper hydroxide was added thereto, and the mixture was refluxed at 80 ° C. for 48 hours. After the reaction was completed, the reaction mixture was cooled to room temperature and concentrated at 50 ° C. 100 L of dichloromethane and 50 L of purified water were added and stirred. 50 L of purified water was added to the organic layer, followed by stirring to separate the organic layer. Thereafter, the mixture was dried over anhydrous magnesium sulfate and the solvent was removed under reduced pressure to yield 3- (3,5-difluorophenoxy) propanenitrile (11 kg, 60%).
1H-NMR (400MHz, CDCl3): δ= 2.87 (t, 2H), 4.19 (t, 2H), 6.44-7.54 (m, 3H) 1 H-NMR (400 MHz, CDCl 3 ): δ = 2.87 (t, 2H), 4.19 (t, 2H), 6.44-7.54 (m, 3H)
실시예 5: 5,7-디플루오로크로만-4-온의 제조Example 5: Preparation of 5,7-difluorochroman-4-one
반응기 A에 진한 황산 30 kg을 투입하였다. 3-(3,5-디플루오로페녹시)프로판니트릴 11 kg을 10~20 ℃에서 투입하고, 50℃ 로 승온하여 교반하였다. 반응이 완결되면 상온으로 냉각하였다. 반응기 B에 정제수 100 L에 투입하고 0℃ 로 냉각하였다. 반응기 A의 반응물을 반응기 B에 투입하였다. 디클로로메탄 110 L을 투입하고, 5% 탄산나트륨 수용액을 이용하여 pH 7로 조절하였다. 교반 후 유기층을 분리하였다. 감압농축 후 헵탄 55L을 투입하고 교반 후 여과하였다 40℃ 에서 진공건조하여 5,7-디플루오로크로만-4-온(9 kg, 80%)을 수득하였다. 30 kg of concentrated sulfuric acid was added to Reactor A. 11 kg of 3- (3,5-difluorophenoxy) propanenitrile was added at 10-20 degreeC, it heated up at 50 degreeC, and stirred. After the reaction was completed, the reaction mixture was cooled to room temperature. 100 L of purified water was added to Reactor B, and it cooled to 0 degreeC. The reaction of Reactor A was introduced into Reactor B. 110 L of dichloromethane was added thereto, and the pH was adjusted to 7 using 5% aqueous sodium carbonate solution. After stirring, the organic layer was separated. After concentrating under reduced pressure, 55 L of heptane was added thereto, stirred, and filtered. The resultant was dried under vacuum at 40 ° C. to obtain 5,7-difluorochroman-4-one (9 kg, 80%).
1H-NMR (400MHz, CDCl3): δ= 2.81 (t, 2H), 4.55 (t, 2H), 6.44-6.53 (m, 2H) 1 H-NMR (400 MHz, CDCl 3 ): delta = 2.81 (t, 2H), 4.55 (t, 2H), 6.44-6.53 (m, 2H)

Claims (22)

  1. 하기 화학식 Ⅰ로 표시되는 화합물과 하기 화학식 Ⅳ로 표시되는 화합물을 반응시켜 하기 화학식 Ⅴ로 표시되는 화합물을 제조하는 제1 단계; 및A first step of preparing a compound represented by the formula (V) by reacting a compound represented by the formula (I) and a compound represented by the formula (IV); And
    상기 화학식 Ⅴ로 표시되는 화합물에 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)를 반응시켜 화학식 Ⅱ의 화합물을 제조하는 제2 단계를 포함하는 화학식 Ⅱ로 표시되는 화합물의 제조 방법: A compound represented by formula (II) comprising a second step of preparing a compound of formula (II) by reacting a compound represented by formula (V) with 2-iodobenzoic acid and potassium peroxymonosulfate Manufacturing method:
    [화학식 I][Formula I]
    Figure PCTKR2016008579-appb-I000012
    Figure PCTKR2016008579-appb-I000012
    [화학식 II][Formula II]
    Figure PCTKR2016008579-appb-I000013
    Figure PCTKR2016008579-appb-I000013
    [화학식 Ⅳ][Formula IV]
    Figure PCTKR2016008579-appb-I000014
    Figure PCTKR2016008579-appb-I000014
    [화학식 Ⅴ] [Formula Ⅴ]
    Figure PCTKR2016008579-appb-I000015
    Figure PCTKR2016008579-appb-I000015
    상기 화학식 Ⅳ에서, X는 할로겐 원자로 플루오로, 염소 또는 요오드로부터 선택될 수 있음.In formula (IV), X may be selected from fluoro, chlorine or iodine as the halogen atom.
  2. 제1항에 있어서, 상기 X는 염소인 것인 화학식 로 표시되는 화합물의 제조 방법.The method of claim 1, wherein X is chlorine.
  3. 제1항에 있어서, 상기 화학식 Ⅰ로 표시되는 화합물과 상기 화학식 Ⅳ로 표시되는 화합물을 반응시켜 상기 화학식 Ⅴ로 표시되는 화합물을 제조하는 상기 제1 단계에서의 상기 반응은 염기 하에 수행되는 O-알킬화 반응인 것인 화학식 Ⅱ로 표시되는 화합물의 제조 방법.The O-alkylation according to claim 1, wherein the reaction in the first step of reacting the compound represented by Chemical Formula I with the compound represented by Chemical Formula IV to produce the compound represented by Chemical Formula V is performed under a base. A method for producing a compound represented by the formula (II) which is a reaction.
  4. 제3항에 있어서, 상기 염기는 수소화칼륨, 수소화나트륨, 수소화리튬 또는 포타슘 t-부톡사이드로부터 선택되는 어느 하나인 화학식 Ⅱ로 표시되는 화합물의 제조 방법.The method of claim 3, wherein the base is any one selected from potassium hydride, sodium hydride, lithium hydride or potassium t-butoxide.
  5. 제1항에 있어서, 상기 화학식 Ⅴ로 표시되는 화합물에 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)를 반응 시키는 제2 단계는 극성 유기 용매 하에 수행되는 것인 화학식 Ⅱ로 표시되는 화합물의 제조 방법.According to claim 1, wherein the second step of reacting the compound represented by Formula V with 2-Iodobenzoic acid and potassium peroxymonosulfate (Potassium peroxymonosulfate) is carried out under a polar organic solvent The manufacturing method of the compound represented by II.
  6. 제5항에 있어서, 상기 극성 용매는, 물, 메탄올, 아세토니트릴 또는 이들의 혼합물인 것인 화학식 Ⅱ로 표시되는 화합물의 제조 방법.The method of claim 5, wherein the polar solvent is water, methanol, acetonitrile, or a mixture thereof.
  7. 하기 화학식 I로 표시되는 화합물을 염기 하에 아크릴로니트릴과 반응시켜 하기 화학식 Ⅵ으로 표시되는 화합물을 제조하는 제1 단계; 및 A first step of preparing a compound represented by the following Chemical Formula VI by reacting a compound represented by the following Chemical Formula I with acrylonitrile under a base; And
    상기 화학식 Ⅵ으로 표시되는 화합물을 가수분해하여 화학식 Ⅱ로 표시되는 화합물을 제조하는 제2 단계를 포함하고, A second step of preparing a compound represented by Chemical Formula II by hydrolyzing the compound represented by Chemical Formula VI,
    상기 제1 단계의 염기는 수산화 구리인 것인 화학식 Ⅱ로 표시되는 화합물의 제조 방법: Method for preparing a compound represented by the formula (II) wherein the base of the first step is copper hydroxide:
    [화학식 I][Formula I]
    Figure PCTKR2016008579-appb-I000016
    Figure PCTKR2016008579-appb-I000016
    [화학식 II][Formula II]
    Figure PCTKR2016008579-appb-I000017
    Figure PCTKR2016008579-appb-I000017
    [화학식 Ⅵ] [Formula VI]
    Figure PCTKR2016008579-appb-I000018
    .
    Figure PCTKR2016008579-appb-I000018
    .
  8. 제7항에 있어서, 화학식 Ⅵ으로 표시되는 화합물을 가수분해하여 화학식 Ⅱ로 표시되는 화합물을 제조하는 제2 단계는 산 존재 하에 수행되는 것인 화학식 Ⅱ로 표시되는 화합물의 제조 방법.The process for preparing a compound represented by the formula (II) according to claim 7, wherein the second step of preparing the compound represented by the formula (II) by hydrolysis of the compound represented by the formula (VI) is performed in the presence of an acid.
  9. 제8항에 있어서, 상기 산은 황산, 염산 또는 인산으로부터 선택되는 어느 하나인 화학식 Ⅱ로 표시되는 화합물의 제조 방법.The method of claim 8, wherein the acid is any one selected from sulfuric acid, hydrochloric acid, or phosphoric acid.
  10. 하기 화학식 로 표시되는 화합물과 하기 화학식 로 표시되는 화합물을 반응시켜 하기 화학식 로 표시되는 화합물을 제조하는 제1 단계; A first step of preparing a compound represented by the following Chemical Formula by reacting a compound represented by the following Chemical Formula with a compound represented by the following Chemical Formula;
    상기 화학식 로 표시되는 화합물에 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)를 반응시켜 화학식 의 화합물을 제조하는 제2 단계; 및A second step of preparing a compound of formula by reacting 2-iodobenzoic acid and potassium peroxymonosulfate with 2-iodobenzoic acid; And
    상기 화학식 로 표시되는 화합물을 고리화 반응시켜 화학식 으로 표시되는 화합물을 제조하는 제3 단계를 포함하는 화학식 으로 표시되는 화합물의 제조 방법: Method for preparing a compound represented by the formula comprising a third step of preparing a compound represented by the formula by the cyclization reaction of the compound represented by the formula:
    [화학식 I][Formula I]
    Figure PCTKR2016008579-appb-I000019
    Figure PCTKR2016008579-appb-I000019
    [화학식 II][Formula II]
    Figure PCTKR2016008579-appb-I000020
    Figure PCTKR2016008579-appb-I000020
    [화학식 III][Formula III]
    Figure PCTKR2016008579-appb-I000021
    Figure PCTKR2016008579-appb-I000021
    [화학식 Ⅳ][Formula IV]
    Figure PCTKR2016008579-appb-I000022
    Figure PCTKR2016008579-appb-I000022
    [화학식 Ⅴ] [Formula Ⅴ]
    Figure PCTKR2016008579-appb-I000023
    Figure PCTKR2016008579-appb-I000023
    상기 화학식 Ⅳ에서, X는 할로겐 원자로 플루오로, 염소 또는 요오드로부터 선택될 수 있음.In formula (IV), X may be selected from fluoro, chlorine or iodine as the halogen atom.
  11. 제10항에 있어서, 상기 X는 염소인 것인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.The method of claim 10, wherein X is chlorine.
  12. 제10항에 있어서, 상기 화학식 Ⅰ로 표시되는 화합물과 상기 화학식 Ⅳ로 표시되는 화합물을 반응시켜 상기 화학식 Ⅴ로 표시되는 화합물을 제조하는 제1 단계에서의 상기 반응은 염기 하에 수행되는 O-알킬화 반응인 것인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.The O-alkylation reaction according to claim 10, wherein the reaction in the first step of reacting the compound represented by Formula (I) with the compound represented by Formula (IV) to prepare the compound represented by Formula (V) is performed under a base. Process for producing a compound represented by the formula (III).
  13. 제12항에 있어서, 상기 염기는 수소화칼륨, 수소화나트륨, 수소화리튬 또는 포타슘 t-부톡사이드로부터 선택되는 어느 하나인 것인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.13. The method of claim 12, wherein the base is any one selected from potassium hydride, sodium hydride, lithium hydride or potassium t-butoxide.
  14. 제10항에 있어서, 상기 화학식 로 표시되는 화합물에 2-요오드화벤조산(2-Iodobenzoic acid) 및 포타슘 퍼옥시모노설페이트(Potassium peroxymonosulfate)를 반응 시키는 제2 단계는 극성 유기 용매 하에 수행되는 것인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.The method of claim 10, wherein the second step of reacting the compound represented by the formula with 2-iodobenzoic acid and potassium peroxymonosulfate is performed under a polar organic solvent. Method for producing a compound represented by.
  15. 제14항에 있어서, 상기 극성 용매는, 물, 메탄올, 아세토니트릴 또는 이들의 혼합물인 것인 화학식 Ⅲ로 표시되는 화합물의 제조 방법.15. The method of claim 14, wherein the polar solvent is water, methanol, acetonitrile or a mixture thereof.
  16. 제10항에 있어서, 화학식 Ⅱ로 표시되는 화합물을 고리화 반응시켜 화학식 Ⅲ으로 표시되는 화합물을 제조하는 제3 단계는 산 조건 하에 수행되는 것인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.The process for preparing a compound represented by formula (III) according to claim 10, wherein the third step of preparing a compound represented by formula (III) by cyclizing the compound represented by formula (II) is performed under acidic conditions.
  17. 제16항에 있어서, 상기 산은 황산, 염산, 또는 인산로부터 선택되는 어느 하나인 것인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.The method of claim 16, wherein the acid is any one selected from sulfuric acid, hydrochloric acid, or phosphoric acid.
  18. 하기 화학식 I로 표시되는 화합물을 염기 하에 아크릴로니트릴과 반응시켜 하기 화학식 Ⅵ 화합물을 제조하는 제1 단계; A first step of preparing a compound of formula (VI) by reacting a compound represented by formula (I) with acrylonitrile under a base;
    상기 화학식 Ⅵ으로 표시되는 화합물을 가수분해하여 화학식 Ⅱ로 표시되는 화합물을 제조하는 제2 단계; 및A second step of preparing a compound represented by Chemical Formula II by hydrolyzing the compound represented by Chemical Formula VI; And
    상기 화학식 Ⅱ로 표시되는 화합물을 고리화 반응시켜 화학식 Ⅲ으로 표시되는 화합물을 제조하는 제3 단계를 포함하고, And a third step of preparing a compound represented by Chemical Formula III by cyclizing the compound represented by Chemical Formula II,
    상기 제1 단계의 염기는 수산화 구리인 것인 화학식 Ⅲ으로 표시되는 화합물의 제조방법: Method for preparing a compound of Formula III wherein the base of the first step is copper hydroxide:
    [화학식 I][Formula I]
    Figure PCTKR2016008579-appb-I000024
    Figure PCTKR2016008579-appb-I000024
    [화학식 II][Formula II]
    Figure PCTKR2016008579-appb-I000025
    Figure PCTKR2016008579-appb-I000025
    [화학식 Ⅲ][Formula III]
    Figure PCTKR2016008579-appb-I000026
    Figure PCTKR2016008579-appb-I000026
    [화학식 Ⅵ][Formula VI]
    Figure PCTKR2016008579-appb-I000027
    .
    Figure PCTKR2016008579-appb-I000027
    .
  19. 제18항에 있어서, 화학식 Ⅵ으로 표시되는 화합물을 가수분해하여 화학식 Ⅱ로 표시되는 화합물을 제조하는 제2 단계는 산 존재 하에 수행되는 것인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.19. The method of claim 18, wherein the second step of preparing a compound represented by Formula II by hydrolyzing the compound represented by Formula VI is carried out in the presence of an acid.
  20. 제19항에 있어서, 상기 산은 황산, 염산 또는 인산으로부터 선택되는 어느 하나인 것인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.20. The method of claim 19, wherein the acid is any one selected from sulfuric acid, hydrochloric acid or phosphoric acid.
  21. 제18항에 있어서, 화학식 Ⅱ로 표시되는 화합물을 고리화 반응시켜 화학식 Ⅲ으로 표시되는 화합물을 제조하는 제3 단계는 산 조건 하에 수행되는 것인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.19. The process for preparing the compound represented by the formula (III) according to claim 18, wherein the third step of preparing a compound represented by the formula (III) by cyclizing the compound represented by the formula (II) is performed under acidic conditions.
  22. 제21항에 있어서, 상기 산은 황산, 염산 또는 인산으로부터 선택되는 어느 하나인 화학식 Ⅲ으로 표시되는 화합물의 제조 방법.The method of claim 21, wherein the acid is any one selected from sulfuric acid, hydrochloric acid or phosphoric acid.
PCT/KR2016/008579 2015-08-04 2016-08-03 Novel method for preparing chromanone derivative WO2017023123A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2018505681A JP6770057B2 (en) 2015-08-04 2016-08-03 New method for producing chromanon derivatives
CN201680045379.5A CN107848943A (en) 2015-08-04 2016-08-03 Prepare the new method of chromanone derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0110245 2015-08-04
KR1020150110245A KR20170016754A (en) 2015-08-04 2015-08-04 New method for preparation of chromanone derivatives

Publications (1)

Publication Number Publication Date
WO2017023123A1 true WO2017023123A1 (en) 2017-02-09

Family

ID=57943373

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/008579 WO2017023123A1 (en) 2015-08-04 2016-08-03 Novel method for preparing chromanone derivative

Country Status (4)

Country Link
JP (3) JP6770057B2 (en)
KR (1) KR20170016754A (en)
CN (1) CN107848943A (en)
WO (1) WO2017023123A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11377434B2 (en) * 2020-07-20 2022-07-05 Hangzhou Duyi Technology Co. Ltd. Methods for preparing substituted chromanone derivatives
WO2023278729A1 (en) * 2021-06-30 2023-01-05 The General Hospital Corporation Chromane imaging ligands

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210020403A (en) 2019-08-14 2021-02-24 엘지전자 주식회사 laundry treatment apparatus
KR20210020406A (en) 2019-08-14 2021-02-24 엘지전자 주식회사 laundry treatment apparatus
KR20210111555A (en) 2020-03-03 2021-09-13 엘지전자 주식회사 laundry treatment apparatus
KR20210111556A (en) 2020-03-03 2021-09-13 엘지전자 주식회사 laundry treatment apparatus
KR20210121402A (en) 2020-03-30 2021-10-08 엘지전자 주식회사 laundry treatment apparatus and operating method of the apparatus

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625042A (en) * 1984-07-09 1986-11-25 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing 6-fluoro-4-chromanone using 3-(4-fluorophenoxy)propionitrile
KR20060060007A (en) * 2003-08-08 2006-06-02 얀센 파마슈티카 엔.브이. 2- (quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
KR20110023895A (en) * 2008-06-25 2011-03-08 바이엘 쉐링 파마 악티엔게젤샤프트 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100915417B1 (en) 2002-06-28 2009-09-03 디일 베게테 디펜스 게엠베하 운트 코 카게 Self-protecting device for an object
WO2008151927A2 (en) * 2007-06-15 2008-12-18 Nycomed Gmbh 6-n-substituted benz imidazole derivatives as acid pump antagonists
TW201348231A (en) * 2012-02-29 2013-12-01 Amgen Inc Heterobicyclic compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625042A (en) * 1984-07-09 1986-11-25 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing 6-fluoro-4-chromanone using 3-(4-fluorophenoxy)propionitrile
KR20060060007A (en) * 2003-08-08 2006-06-02 얀센 파마슈티카 엔.브이. 2- (quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
KR20110023895A (en) * 2008-06-25 2011-03-08 바이엘 쉐링 파마 악티엔게젤샤프트 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THOTTUMKARA, ARUN P. ET AL.: "In Situ Generation of o-Iodoxybenzoic Acid (IBX) and the Catalytic Use of It in Oxidation Reactions in the Presence of Qxone as a Co-oxidan", ORG. LETT., vol. 7, no. 14, 2005, pages 2933 - 2936, XP055361796 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11377434B2 (en) * 2020-07-20 2022-07-05 Hangzhou Duyi Technology Co. Ltd. Methods for preparing substituted chromanone derivatives
WO2023278729A1 (en) * 2021-06-30 2023-01-05 The General Hospital Corporation Chromane imaging ligands

Also Published As

Publication number Publication date
CN107848943A (en) 2018-03-27
KR20170016754A (en) 2017-02-14
JP2020097607A (en) 2020-06-25
JP2018523662A (en) 2018-08-23
JP6948419B2 (en) 2021-10-13
JP2020180134A (en) 2020-11-05
JP6770057B2 (en) 2020-10-14

Similar Documents

Publication Publication Date Title
WO2017023123A1 (en) Novel method for preparing chromanone derivative
CN108409625B (en) Preparation method of 2-pyrrolidone compound
AU2018308038B2 (en) Improved process for preparing aminopyrimidine derivatives
CN107857743B (en) Method for preparing roxatidine acetate hydrochloride and intermediate
AU2018385820B2 (en) Intermediates for optically active piperidine derivatives and preparation methods thereof
CN110590635A (en) Preparation method of levetiracetam and intermediate thereof
WO2016105172A2 (en) A method for preparing gadobutrol
WO2010036048A2 (en) Method for preparing montelukast sodium salts
AU2018308039B2 (en) Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same
CN113372336A (en) Preparation method and application of brexpiprazole
WO2022092774A1 (en) Method for selectively synthesizing 3,6'-dithiopomalidomide from pomalidomide
KR101894091B1 (en) New method for preparation of chromanone derivatives
WO2017023124A1 (en) Novel method for preparing chromanol derivative
WO2021210920A1 (en) Method for producing ramelteon, and intermediate compound used for same
WO2016076573A2 (en) Method for preparing blonanserin and intermediate therefor
WO2010074387A1 (en) Aza-bicyclo[2.2.1] heptene derivatives, preparation method thereof, and method for preparing oseltamivir intermediates using the same
WO2020085616A1 (en) Method for preparing apixaban
CN110563721A (en) Preparation method of azasetron hydrochloride
WO2011155689A2 (en) Method for preparing an intermediate of pitavastatin or of the salt thereof
EP3356372A1 (en) Novel process for preparing thienopyrimidine compound and intermediates used therein
WO2023200189A1 (en) Synthesis method for 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative
WO2017209458A1 (en) Novel method for preparing 4'-hydroxy-4-biphenylcarboxylic acid
CN108658931A (en) A kind of preparation method of Raltitrexed key intermediate
WO2021107478A1 (en) A method for preparing novel crystalline forms of 1-(4-benzyloxy-benzyl)-3-methyl-thiourea
WO2023013973A1 (en) Novel method for preparing rucaparib

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16833359

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2018505681

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16833359

Country of ref document: EP

Kind code of ref document: A1